nach oben

Erschienen in:

22.06.2018 | Original Contribution

Education and employment trajectories from childhood to adulthood in individuals with 22q11.2 deletion syndrome

verfasst von: Mariela Mosheva, Virginie Pouillard, Yael Fishman, Lydia Dubourg, Dafna Sofrin-Frumer, Yaffa Serur, Abraham Weizman, Stephan Eliez, Doron Gothelf, Maude Schneider

Erschienen in: European Child & Adolescent Psychiatry | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

22q11.2 deletion syndrome (22q11.2DS) is the most common known microdeletion in humans occurring in 1 out of 2000–4000 live births, with increasing numbers of individuals with the microdeletion living into adulthood. The aim of the study was to explore the education and employment trajectories of individuals with 22q11.2DS from childhood to adulthood in a large cohort composed of two significant samples. 260 individuals with 22q11.2DS, 134 male and 126 female, aged 5–59 years (mean age 21.3 ± 10.8 years) were evaluated at two sites, Geneva (GVA) and Tel Aviv (TA). Psychiatric comorbidities, IQ score, and adaptive functioning were assessed using gold-standard diagnostic tools. Demographic factors, such as data about education, employment, marital status, and living status, were collected. Children entering elementary school (5–12 years) were significantly more likely to attend a mainstream school, while adolescents were significantly more likely to attend special education schools (p < 0.005). Cognitive abilities, and not adaptive functioning, predicted school placement. Among adults with 22q11.2DS (n = 138), 57 (41.3%) were unemployed, 46 (33.3%) were employed in open market employment, and 35 (25.4%) worked in assisted employment. In adulthood, adaptive functioning more than cognitive abilities predicted employment. Surprisingly, psychotic spectrum disorders were not found to be associated with employment. Individuals with 22q11.2DS are characterized by heterogeneity in educational and employment profiles. We found that cognitive abilities and adaptive functioning, and not the presence of psychiatric disorders, are key factors in school placement and employment. These factors should, therefore, be taken into account when planning optimal development of individuals with 22q11.2DS.

Nur mit Berechtigung zugänglich

Grati FR, Molina Gomes D, Ferreira JCPB et al (2015) Prevalence of recurrent pathogenic microdeletions and microduplications in over 9500 pregnancies. Prenat Diagn 35:801–809. https://doi.org/10.1002/pd.4613 CrossRefPubMed

Shprintzen RJ (2008) Velo-cardio-facial syndrome: 30 years of study. Dev Disabil Res Rev 14:3–10. https://doi.org/10.1002/ddrr.2.Velo-Cardio-Facial CrossRefPubMedPubMedCentral

Schneider M, Debbané M, Bassett AS et al (2014) Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the international consortium on brain and behavior in 22q11.2 deletion syndrome. Am J Psychiatry. https://doi.org/10.1176/appi.ajp.2013.13070864 CrossRefPubMedPubMedCentral

McDonald-McGinn DM, Sullivan KE, Marino B et al (2015) 22Q11.2 deletion syndrome. Nat Rev Dis Prim. https://doi.org/10.1038/nrdp.2015.71 CrossRefPubMed

Fung WLA, Butcher NJ, Costain G et al (2015) Practical guidelines for managing adults with 22q11.2 deletion syndrome. Genet Med 17:599–609. https://doi.org/10.1038/gim.2014.175 CrossRefPubMedPubMedCentral

Vogels A, Schevenels S, Cayenberghs R et al (2014) Presenting symptoms in adults with the 22q11 deletion syndrome. Eur J Med Genet 57:157–162. https://doi.org/10.1016/j.ejmg.2014.02.008 CrossRefPubMed

Chow EWC, Watson M, Young DA, Bassett AS (2006) Neurocognitive profile in 22q11 deletion syndrome and schizophrenia. Schizophr Res 87:270–278. https://doi.org/10.1016/j.schres.2006.04.007 CrossRefPubMedPubMedCentral

Schneider M, Debbané M, Bassett AS et al (2014) Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the international consortium on brain and behavior in 22q11.2 deletion syndrome. Am J Psychiatry 171:627–639. https://doi.org/10.1176/appi.ajp.2013.13070864 CrossRefPubMedPubMedCentral

Green T, Gothelf D, Glaser B et al (2009) Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. J Am Acad Child Adolesc Psychiatry 48:1060–1068. https://doi.org/10.1097/CHI.0b013e3181b76683 CrossRefPubMed

10.

Norkett EM, Lincoln SH, Gonzalez-Heydrich J, D’Angelo EJ (2017) Social cognitive impairment in 22q11 deletion syndrome: a review. Psychiatry Res 253:99–106. https://doi.org/10.1016/j.psychres.2017.01.103 CrossRefPubMed

11.

Tang KL, Antshel KM, Fremont WP, Kates WR (2015) Behavioral and psychiatric phenotypes in 22q11.2 deletion syndrome. J Dev Behav Pediatr 36:639–650. https://doi.org/10.1097/DBP.0000000000000210 CrossRefPubMedPubMedCentral

12.

European Agency for Development in Special Needs Education (2012) Special needs education

13.

Reilly C, Stedman L (2014) Supporting children with genetic syndromes in the classroom: the example of 22q deletion syndrome. Supp Learn. https://doi.org/10.1111/1467-9604.12029 CrossRef

14.

Crawford C (2011) The employment of people with intellectual disabilities in Canada: a statistical profile. Institute for Research and Development on Inclusion and Society (IRIS), Toronto

15.

Verdonschot MM, de Witte LP, Reichrath E et al (2009) Community participation of people with an intellectual disability: a review of empirical findings. J Intellect Disabil Res 53:303–318. https://doi.org/10.1111/j.1365-2788.2008.01144.x CrossRefPubMed

16.

Schneider M, Van der Linden M, Glaser B et al (2012) Preliminary structure and predictive value of attenuated negative symptoms in 22q11.2 deletion syndrome. Psychiatry Res 196:277–284. https://doi.org/10.1016/j.psychres.2011.08.017 CrossRefPubMed

17.

Aman MG, Buican B, Arnold LE (2003) Methylphenidate treatment in children with borderline IQ and mental retardation: analysis of three aggregated studies. J Child Adolesc Psychopharmacol 13:29–40. https://doi.org/10.1089/104454603321666171 CrossRefPubMed

18.

Butcher NJ, Chow EW, Costain G et al (2012) Functional outcomes of adults with 22q11.2 deletion syndrome. Genet Med 14:836–843. https://doi.org/10.1038/gim.2012.66 CrossRefPubMedPubMedCentral

19.

McDonald-McGinn DM, Tonnesen MK, Laufer-Cahana A et al (2001) Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net! Genet Med 3:23–29. https://doi.org/10.1097/00125817-200101000-00006 CrossRefPubMed

20.

Michaelovsky E, Frisch A, Carmel M et al (2012) Genotype-phenotype correlation in 22q11.2 deletion syndrome. BMC Med Genet 13:122. https://doi.org/10.1186/1471-2350-13-122 CrossRefPubMedPubMedCentral

21.

Kaufman J, Birmaher B, Brent D et al (1997) Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980–988. https://doi.org/10.1097/00004583-199707000-00021 CrossRefPubMed

22.

First M, Spitzer R, Gibbon M, Williams J (1996) Structured clinical interview for DSM-IV-TR axis I disorders (SCID-I)

23.

Reich W (2000) Diagnostic interview for children and adolescents (DICA). J Am Acad Child Adolesc Psychiatry 39:59–66. https://doi.org/10.1097/00004583-200001000-00017 CrossRefPubMed

24.

Wechsler D (1991) Wechsler intelligence scale for children, 3rd edn. Psychol. Corp, San Antonio

25.

Wechsler D (2003) Wechsler intelligence scale for children—fourth edition (WISC-IV). Psychol. Corp, San Antonio

26.

Wechsler D (1997) WAIS-III: Wechsler adult intelligence scale. Administration and scoring manual, 3rd edn. Psychol. Corp, San Antonio

27.

Balboni G, Pedrabissi L, Molteni M, Villa S (2001) Discriminant validity of the Vineland Scales: score profiles of individuals with mental retardation and a specific disorder. Am J Ment Retard 106:162–172. https://doi.org/10.1352/0895-8017(2001)106<0162:DVOTVS>2.0.CO;2CrossRefPubMed

28.

Sparrow SS, Cicchetti VDBA (2005) Vineland adaptive behavior scales, 2nd edn. Circle Pines, MN

29.

Gothelf D, Eliez S, Thompson T et al (2005) COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome. Nat Neurosci 8:1500–1502. https://doi.org/10.1038/nn1572 CrossRefPubMed

30.

Vorstman JAS, Breetvelt EJ, Duijff SN et al (2015) Cognitive decline preceding the onset of psychosis in patients with 22q112 deletion syndrome. JAMA Psychiatry 72:377. https://doi.org/10.1001/jamapsychiatry.2014.2671 CrossRefPubMedPubMedCentral

31.

Duijff SN, Klaassen PWJ, Swanenburg de Veye HFN et al (2013) Cognitive and behavioral trajectories in 22q11DS from childhood into adolescence: a prospective 6-year follow-up study. Res Dev Disabil 34:2937–2945. https://doi.org/10.1016/j.ridd.2013.06.001 CrossRefPubMed

32.

Duijff SN, Klaassen PWJ, Swanenburg De Veye HFN et al (2012) Cognitive development in children with 22q11.2 deletion syndrome. Br J Psychiatry 200:462–468. https://doi.org/10.1192/bjp.bp.111.097139 CrossRefPubMed

33.

Coghill DR, Banaschewski T, Soutullo C et al (2017) Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry 26:1283–1307. https://doi.org/10.1007/s00787-017-0986-y CrossRefPubMedPubMedCentral

34.

Niarchou M, Martin J, Thapar A et al (2015) The clinical presentation of attention deficit-hyperactivity disorder (ADHD) in children with 22q11.2 deletion syndrome. Am J Med Genet Part B Neuropsychiatr Genet 168:730–738. https://doi.org/10.1002/ajmg.b.32378 CrossRef

35.

Tang SX, Yi JJ, Calkins ME et al (2014) Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated. Psychol Med 44:1267–1277. https://doi.org/10.1017/S0033291713001669 CrossRefPubMed

36.

Angkustsiri K, Leckliter I, Tartaglia N et al (2012) An examination of the relationship of anxiety and intelligence to adaptive functioning in children with chromosome 22q11.2 deletion syndrome. J Dev Behav Pediatr 33:713–720. https://doi.org/10.1097/DBP.0b013e318272dd24 CrossRefPubMedPubMedCentral

37.

Lima K, Folling I, Eiklid KL et al (2010) Age-dependent clinical problems in a Norwegian national survey of patients with the 22q11.2 deletion syndrome. Eur J Pediatr 169:983–989. https://doi.org/10.1007/s00431-010-1161-3 CrossRefPubMed

38.

Mosheva M, Eyal S, Weisman O et al (2017) Higher adaptive functioning and lower rate of psychotic comorbidity in married versus unmarried individuals with 22q11.2 deletion syndrome. Am J Med Genet Part A. https://doi.org/10.1002/ajmg.a.38555 CrossRefPubMed

39.

Lindstrom L, Kahn LG, Lindsey H (2013) Navigating the early career years: barriers and strategies for young adults with disabilities. J Vocat Rehabil 39:1–12. https://doi.org/10.3233/JVR-130637 CrossRef

40.

Meeting OE (2010) Mental health, disability and work. Organ Econ Co-operation Dev Dir Employment Labour Soc Aff 26–28

41.

Hercher L, Bruenner G (2008) Living with a child at risk for psychotic illness: the experience of parents coping with 22q1.1 deletion syndrome: An exploratory study. Am J Med Genet Part A 146:2355–2360. https://doi.org/10.1002/ajmg.a.32466 CrossRef

42.

Rosenheck R, Mueser KT, Sint K et al (2017) Supported employment and education in comprehensive, integrated care for first episode psychosis: effects on work, school, and disability income. Schizophr Res 182:120–128. https://doi.org/10.1016/j.schres.2016.09.024 CrossRefPubMed

Titel: Education and employment trajectories from childhood to adulthood in individuals with 22q11.2 deletion syndrome
verfasst von: Mariela Mosheva
Virginie Pouillard
Yael Fishman
Lydia Dubourg
Dafna Sofrin-Frumer
Yaffa Serur
Abraham Weizman
Stephan Eliez
Doron Gothelf
Maude Schneider
Publikationsdatum: 22.06.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: European Child & Adolescent Psychiatry / Ausgabe 1/2019
Print ISSN: 1018-8827
Elektronische ISSN: 1435-165X
DOI: https://doi.org/10.1007/s00787-018-1184-2

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Maternal breastfeeding and attention-deficit/hyperactivity disorder in children: a meta-analysis

Is REThink therapeutic game effective in preventing emotional disorders in children and adolescents? Outcomes of a randomized clinical trial

A prospective cohort study of biopsychosocial factors associated with childhood urinary incontinence

European Multicentre Tics in Children Studies (EMTICS): protocol for two cohort studies to assess risk factors for tic onset and exacerbation in children and adolescents